CAS 1765-93-1 | ASLAN002-003
(World's Largest Pharmaceutical Supplier)

CAS 1765-93-1 is a synthetic cannabinoid that has been banned in many countries due to its high toxicity. It is structurally similar to other synthetic cannabinoids and belongs to the group of non-THC cannabinoids.

Compared to other synthetic cannabinoids, CAS 1765-93-1 has a relatively low toxicity, but it is still harmful to human health. It can cause a range of effects including euphoria, relaxation, and cognitive impairment, but these effects are often short-lived and accompanied by serious side effects.

The pharmacological effects of CAS 1765-93-1 are mediated through interactions with the body's endocannabinoid system. It binds to the cannabinoid receptors CB1 and CB2, which are located in the brain and nervous system, and affects the way the body processes emotions, thoughts, and sensations.

In addition to its recreational use, CAS 1765-93-1 has also been investigated for its potential medical applications. Preclinical studies have shown that it may have anti-inflammatory, analgesic, and anti-tumor properties. However, these findings need to be confirmed in human studies before any conclusions can be drawn.

The toxicity of CAS 1765-93-1 is a major concern, as it has been associated with several cases of overdose and death. The potency and toxicity of this substance are difficult to predict, and its use carries significant risks. Therefore, it is strongly recommended that individuals avoid using CAS 1765-93-1 or any other untested synthetic cannabinoids.